Author

C. M. Rush

Primary ORCID profile (0000-0002-3044-9488 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

C. M. RushiD1 paper · Australian Institute of Tropical Health and Medicine

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

D. H. Lum· 2 shared J. Gertz· 2 shared J. M. Vahrenkamp· 2 shared Z. Blanchard· 2 shared A. C. Rodriguez· 1 shared C. Brown· 1 shared C. R. Hagan· 1 shared C.-H. Yang· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. H. Lum

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Characterization of a novel estrogen- and progesterone-responsive endometrial cancer cell line: HCI-EC-23

C. M. Rush, Z. Blanchard, J. T. Polaski, K. S. Osborne, K. Osby, J. M. Vahrenkamp, C.-H. Yang, D. H. Lum, C. R. Hagan, K. K. Leslie, M. A. Pufall, K. W. Thiel, J. Gertz

This paper introduces a new endometrial cancer cell line, HCI-EC-23, which responds to estrogen and progesterone, and shows it has similar estrogen-responsive gene regulation to Ishikawa cells.

bioRxiv · Aug 25, 2022Cancer Biology

Allele-specific gene regulation, phenotypes, and therapeutic vulnerabilities in estrogen receptor alpha mutant endometrial cancer

Z. Blanchard, C. M. Rush, S. Arnesen, J. M. Vahrenkamp, A. C. Rodriguez, E. A. Jarboe, C. Brown, M. E. K. Chang, M. R. Flory, H. Mohammed, K. Modzelewska, D. H. Lum, J. Gertz

This study investigates ER mutations in endometrial cancer, showing they alter gene expression and promote cancer phenotypes, and identifies potential therapeutic targets.

bioRxiv · Jun 13, 2022Cancer Biology